Atezolizumab Plus CArboplatin Plus Nab-paclitaxel

Clinical trial NCT05266937 · UNKNOWN

Trial details

NCT number: NCT05266937
Sponsor: Consorzio Oncotech
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Triple Negative Breast Cancer PD-L1 Gene Mutation

Start date: 2020-07-03
Primary completion: 2024-07-03
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.